期刊
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
卷 22, 期 1, 页码 73-82出版社
KARGER
DOI: 10.1159/000093316
关键词
Alzheimer's disease; apolipoprotein E; cognition; activities of daily living
资金
- NIDA NIH HHS [K24-DA15105] Funding Source: Medline
- NIMH NIH HHS [P30-MH30929] Funding Source: Medline
- NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030929] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [K24DA015105] Funding Source: NIH RePORTER
Objective: The apolipoprotein E ( ApoE) epsilon 4 allele is a well-documented genetic risk factor for Alzheimer's disease ( AD). Its role, if any, in the progression of cognitive and functional impairment in AD has been the subject of discrepant reports in the literature. This study aimed to determine whether ApoE epsilon 4 dose is related to the progression of cognitive and functional decline in AD patients by combined retrospective and prospective analyses. Methods: A sample of 366 AD patients was genotyped for ApoE. Subjects received tests of cognition (Mini-Mental State Examination, MMSE; Alzheimer's Disease Assessment Scale-Cognitive subscale, ADASCog) and daily function ( Instrumental Activities of Daily Living, IADL; Alzheimer's Disease Cooperative Study-Activities of Daily Living, ADCS-ADL) at baseline and at multiple subsequent time points during their participation in a variety of research protocols. In retrospective analyses, scores on baseline cognitive and functional measures were compared cross-sectionally among genotype groups, controlling for duration of symptoms. In prospective analyses, longitudinal rates of change for each measure were computed by linear regression and compared across genotype groups. Results: No association was observed between ApoE epsilon 4 dose and any of the retrospective or prospective measures of cognitive or functional decline in this AD patient sample. Conclusions: Although ApoE epsilon 4 increases the risk for AD and decreases the age of disease onset in population studies, it did not significantly influence the rate of disease progression in cognitive or functional domains in our sample. Copyright (C) 2006 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据